Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italia, Testo: Roma
Alessandro Calarco
19 anni di esperienza
Clinica certificata da :
| Italia | Turchia | Austria | |
| Asportazione di tumore testicolare | - | da $4,500 | da $8,500 |
| Protesi testicolare | - | da $1,500 | da $3,500 |
| Orchiectomia | - | da $2,570 | da $9,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Asportazione di tumore testicolare. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Asportazione di tumore testicolare al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Asportazione di tumore testicolare e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Asportazione di tumore testicolare.
Dr. Caterina Lania is a consultant in Andrology and Urology at San Raffaele Hospital in Milan. She focuses on diagnosing and treating urogenital conditions in both men and women. Her areas of expertise include infertility, impotence, bladder tumors, and genital disorders, whether congenital or acquired.
Dr. Lania graduated from the University of Milan. She has published over 150 scientific articles. She is also active in laboratory research on genitourinary diseases. Dr. Lania regularly takes part in national and international medical congresses, showing her dedication to professional growth.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.